Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  recombinant human EGF-rP64K/Montanide ISA 51 vaccine
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
CIMAvax Vaccine and Nivolumab in Treating Patients with Stage IIIB-IV Non-small Cell Lung Cancer
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: I 286816, NCI-2016-01467, NCT02955290
Start Over